AntriaBio Initiates Effort to Raise up to $12 Million in a Private Placement
July 01, 2013 08:30 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwired - Jul 1, 2013) - AntriaBio, Inc. (OTCQB: ANTB), a clinical-stage biopharmaceutical company developing therapies for the treatment of diabetes, announced today that as a...
AntriaBio Appoints Two Industry Leaders to Its Management Team
February 19, 2013 10:37 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwire - Feb 19, 2013) - AntriaBio, Inc. (OTCQB: ANTB) is pleased to announce the appointment, on January 31, 2013, of two new members to its management team: Nevan Elam, as...
AntriaBio Announces Stock Ticker Symbol Change to ANTB
February 08, 2013 10:44 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwire - Feb 8, 2013) - AntriaBio, Inc. ("AntriaBio") today announced that FINRA has approved a change of the Company's stock ticker symbol. Effective today, the Company's...
UPDATE: AntriaBio Completes Merger and Elects Board of Directors
February 06, 2013 13:10 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwire - Feb 6, 2013) - AntriaBio Delaware, Inc. f/k/a AntriaBio, Inc. ("AntriaBio Delaware") (OTCQB: FMYY), a biopharmaceutical company developing novel therapeutics for the...
AntriaBio Completes Merger and Elects Board of Directors
February 06, 2013 11:47 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwire - Feb 6, 2013) - AntriaBio Delaware, Inc. f/k/a AntriaBio, Inc. ("AntriaBio Delaware"), a biopharmaceutical company developing novel therapeutics for the diabetes...
AntriaBio Acquires Assets of PR Pharmaceuticals and Announces Intent to Merge With a Public Company
January 07, 2013 09:00 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwire - Jan 7, 2013) - AntriaBio, Inc., a biopharmaceutical company developing novel therapeutics for the diabetes market, is pleased to announce the acquisition of the...